Real-world efficacy of EBR/GZR in HCV GT1 patients with multiple comorbidities and medications: results from the DHC-R

H Hinrichsen,A Stoehr,M Cornberg,H Klinker,R Heyne,C John,KG Simon,M Bilzer,V Guenther,V Witte,S Zeuzem

Zeitschrift für Gastroenterologie36. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber（2020）

引用 0|浏览5

暂无评分

摘要

Until now, the impact of comorbidities and DDIs on the outcome of elbasvir/grazoprevir (EBR/GZR) treatment is rather unclear. The present analysis of the DHC-R real-world cohort was aimed to assess the clinical relevance of co-morbidities and DDIs in patients (pts) with chronic HCV GT1 infection undergoing treatment with EBR/GZR.

查看译文

关键词

hcv gt1 patients,ebr/gzr,multiple comorbidities,ebr/gzr,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要